Skip to main content

Advertisement

SpringerLink
Log in

The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line

  • Original Article
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Previous work from our laboratory demonstrated that glucosylceramide synthase (GCS) and multidrug resistance 1 gene (MDR1) are co-overexpressed in drug-resistant leukemia cells. We hypothesized that GCS and MDR1 may interact. In this study, we used RNA interference (RNAi) to silence the GCS or MDR1 gene in K562/AO2 drug-resistant cells. The sensitivity of cells to different treatments with doxorubicin was evaluated. We used Taqman probe fluorescence real-time quantitative PCR, and detected expression of GCS and MDR1 mRNAs in different interfering groups. Intracellular mean fluorescence intensity (MFI), which represents rhodamine123 (rh123) retention, was determined by flow cytometry (FCM). An MTT cytotoxicity assay showed that the 50% inhibition concentration (IC50) of doxorubicin of K562/AO2 cells (138.25 ± 3.75 µg/ml) was significantly higher than that of K562 drug-sensitive cells (2.125 ± 0.125 µg/ml), and that IC50 was evidently lower in K562/AO2 cells, whether it was transfected with a small interfering RNA (siRNA) targeting GCS (GCSsiRNA) or one targeting MDR1 (MDR1siRNA). Compared with untreated K562/AO2 cells, the inhibition rates of GCS mRNA in the cells transfected with GCSsiRNA for 9 and 36 h were 56.67 ± 9.29% (p < 0.05) and 74 ± 6.38% (p < 0.05), respectively. Interestingly, the expression of MDR1 mRNA was also inhibited to 51.7 ± 4.5% (p < 0.05) 36 h after transfection with GCSsiRNA, but there was no significant difference in MDR1 expression at 9 h post-transfection in cells treated with GCSsiRNA and a negative control. It is well known that rh123 retention in cells results from an efflux function of P-glycoprotein (P-gp). In K562 cells, rh123 retention was much higher than in K562/AO2 cells (p < 0.01). We also noted that rh123 retention in the K562/AO2 cells transfected with GCSsiRNA for 48 h was significantly higher than in the negative control group. In conclusion, we show in the present study that inhibition of the GCS gene affects the expression of MDR1 mRNA and P-gp function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Friedenberg WR, Tallman MS, Brodsky I, Paietta E, Rowe JM, Lee SJ, Rowland Jr KM, Schnetzer GW, Reed JC. Modified VAD and PSC-833 in the treatment of resistant or relapsing chronic lymphocytic leukemia (E4996): a trial of the Eastern Cooperative Oncology Group. Leuk Res. 2004;28(8):813–9.

    Article  CAS  PubMed  Google Scholar 

  2. Carrion C, Madariaga MA, Domingo JC. In vitro cytotoxic study of immunoliposomal doxorubicin targeted to human CD34+ leukemic cells. Life Sci. 2004;75(3):313–28.

    Article  CAS  PubMed  Google Scholar 

  3. Sikic BI, Fisher GA, Lum BL, Halsey J, Beketic-Oreskovic L, Chen G. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother Pharmacol. 1997;40(7):S13–9.

    Article  CAS  PubMed  Google Scholar 

  4. Ueda K, Cardarelli C, Gottesman MM, Pastan I. Expression of a full-length cDNA for the human “MDR1”gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA. 1987;84(9):3004–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385–427.

    Article  CAS  PubMed  Google Scholar 

  6. Broxterman HJ, Sonneveld P, Feller N, Ossenkoppele GJ, Wahrer DC, Eekman CA, Schoester M, Lankelma J, Pinedo HM, Lowenberg B, Schuurhuis GJ, et al. Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity. Blood. 1996;87(11):4809–16.

    CAS  PubMed  Google Scholar 

  7. Hirose M, Hosoi E, Hamano S, Jalili A. Multidrug resistance in childhood hematologic malignancies. J Med Invest. 2003;50(3):126–35.

    PubMed  Google Scholar 

  8. Arceci RJ. Clinical significance of P-glycoprotein in multidrug resistance malignancies. Blood. 1993; 81(9):2215–11.

    CAS  PubMed  Google Scholar 

  9. Morjani H, Aouali N, Belhoussine R, Veldman RJ, Levada T, Manfait M. Elevation of glucosylceramide in multidrug-resistant cancer cells and accumulation in cytoplasmic droplets. Int Cancer. 2001;94(2):157–65.

    Article  CAS  Google Scholar 

  10. Gouaze V, Yu JY, Bleicher RJ, Han TY, Liu YY, Wang H, Gottesman MM, Bitterman A, Giuliano AE, Cabot MC. Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. Mol Cancer Ther. 2004;3(5):633–9.

    CAS  PubMed  Google Scholar 

  11. Liu YY, Han TY, Giuliano AE, Hansen N, Myles C. Cabot Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem. 2000;275(10):7138–43.

    Article  CAS  PubMed  Google Scholar 

  12. Ping X, Shen YF, Shi YP, Ge SM, Gu ZH, Wang J, Mu HJ, Zhang B, Qiao WZ, Xie KM, et al. Overexpression of glucosylceramide synthase in associated with multidrug resistance of leukemia cells. Leuk Res. 2008;32(3):475–80.

    Article  Google Scholar 

  13. Ricci C, Onida F, Ghidoni R. Sphingolipid players in the leukemia arena. Biochim Biophys Acta. 2006;1758(12):2121–32.

    Article  CAS  PubMed  Google Scholar 

  14. Gouaze V, Liu YY, Carlton S, Prickett CS, Jing Y, Giuliano AE, Myles C, et al. Cabot glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs. Cancer Res. 2005;65(9):3861–7.

    Article  CAS  PubMed  Google Scholar 

  15. Liu Y, Xie KM, Yang GQ, Bai XM, Shi YP, Mu HJ, Qiao WZ, Bin Zhang B, Xie P. GCS induces multidrug resistance by regulating apoptosis-related genes in K562/AO2 cell line. Cancer Chemother Pharmacol. 2009;66(3):433–9.

    Article  PubMed  Google Scholar 

  16. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976;455(1):152–62.

    Article  CAS  PubMed  Google Scholar 

  17. Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K, et al. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta. 2000;1485(2-3):63–99.

    Article  CAS  PubMed  Google Scholar 

  18. Kohyama-koganaya A, Hirabayashi Y. Role of glucosylceramide synthase as negative regulator for ceramide. Tanpakushitsu Kakusan Koso. 2002;47(4 Suppl):470–5.

    CAS  PubMed  Google Scholar 

  19. Gerrard G, Butters TD, Ganeshaguru K, Mehta AB. Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. Eur J Pharmacol. 2009;609(1–3):34–9.

    Article  CAS  PubMed  Google Scholar 

  20. De Rosa MF, Sillence D, Ackerley C, Lingwood C. Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis. J Biol Chem. 2004;279(9):7867–76.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathophysiology, Soochow University, Suzhou, 215123, China

    Yang-Yang Zhang & Ke-Ming Xie

  2. Department of Pathology, Xi’an Central Hospital, Xi’an, Shanxi, China

    Guo-Qing Yang

  3. Central Laboratory, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu, China

    Hui-Jun Mu, Ying Yin, Bin Zhang & Ping Xie

Authors
  1. Yang-Yang Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ke-Ming Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guo-Qing Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hui-Jun Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ying Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Bin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ping Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ping Xie.

About this article

Cite this article

Zhang, YY., Xie, KM., Yang, GQ. et al. The effect of glucosylceramide synthase on P-glycoprotein function in K562/AO2 leukemia drug-resistance cell line. Int J Hematol 93, 361–367 (2011). https://doi.org/10.1007/s12185-011-0798-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-011-0798-7

Keywords

Search

Navigation